[Other] Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial

fercuneo Post time 4 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-04-11 19:23
Reward10points

Jongbloed, E. M., Wortelboer, N., de Weerd, V., Beaufort, C. M., Ruigrok-Ritstier, K., Van, M. N., Kraan, J., van Zweeden, A. A., van der Padt-Pruijsten, A., Hamming, L. C., Konings, I. R., Sonke, G. S., Oomen-de Hoop, E., Martens, J. W. M., Jager, A., & Wilting, S. M. (2025). Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial. Nature medicine, 31(11), 3662每3667. https://doi.org/10.1038/s41591-025-03935-w

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
ix91 Post time 4 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    31540


Return to the list